NDC 55566-6700

CLENPIQ

Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid

CLENPIQ is a Oral Liquid in the Human Prescription Drug category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is Sodium Picosulfate; Magnesium Oxide; Anhydrous Citric Acid.

• Product ID: 55566-6700_0cb1c1af-e062-48f1-9796-8728c11c89f5
• NDC: 55566-6700
• Product Type: Human Prescription Drug
• Proprietary Name: CLENPIQ
• Generic Name: Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2018-06-29
• Marketing Category: NDA / NDA
• Application Number: NDA209589
• Labeler Name: Ferring Pharmaceuticals Inc.
• Substance Name: SODIUM PICOSULFATE; MAGNESIUM OXIDE; ANHYDROUS CITRIC ACID
• Active Ingredient Strength: 10 mg/160mL; g/160mL; g/160mL
• Pharm Classes: Increased Large Intestinal Motility [PE],Stimulant Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 55566-6700-1

2 BOTTLE in 1 CARTON (55566-6700-1) > 160 mL in 1 BOTTLE (55566-6700-0)

• Marketing Start Date: 2018-06-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 55566-6700-1 [55566670001]

CLENPIQ LIQUID

• Marketing Category: NDA
• Application Number: NDA209589
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2018-06-29

NDC 55566-6700-0 [55566670000]

CLENPIQ LIQUID

• Marketing Category: NDA
• Application Number: NDA209589
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2018-06-29

Drug Details

Active Ingredients

Ingredient	Strength
SODIUM PICOSULFATE	10 mg/160mL

OpenFDA Data

• SPL SET ID: ea24a07b-34ca-4da4-ba69-73bbf44de20d
• Manufacturer:
  • Ferring Pharmaceuticals Inc.
• UNII:
  • XF417D3PSL
  • 3A3U0GI71G
  • LR57574HN8
• RxNorm Concept Unique ID - RxCUI:
  • 1994540
  • 1991509

Pharmacological Class

• Increased Large Intestinal Motility [PE]
• Stimulant Laxative [EPC]
• Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• Calculi Dissolution Agent [EPC]
• Magnesium Ion Exchange Activity [MoA]
• Osmotic Laxative [EPC]
• Osmotic Activity [MoA]
• Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
• Increased Large Intestinal Motility [PE]
• Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Acidifying Activity [MoA]
• Calculi Dissolution Agent [EPC]
• Anti-coagulant [EPC]
• Decreased Coagulation Factor Activity [PE]
• Calcium Chelating Activity [MoA]

Medicade Reported Pricing

55566670001 CLENPIQ SOLUTION

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "CLENPIQ" or generic name "Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid"

NDC	Brand Name	Generic Name
55566-6700	CLENPIQ	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
55566-6800	CLENPIQ	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
72032-6700	CLENPIQ	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
55566-9300	PREPOPIK	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
55566-9700	PREPOPIK	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID